Ramita Tandon
As the Chief Clinical Trials Officer at Walgreens, Ramita Tandon is responsible for leading and driving growth for the Company’s new clinical trials business. In her role, Ramita works across the healthcare and life sciences industries to enable next-generation clinical trials so that breakthrough treatments reach patients faster. Ramita’s motto is “talk less and do more.” Every day, she lives this out by showing and setting industry standards on addressing access and health equity. She and her team are working to make clinical research an inherent care option across this nation when the standard of therapy is not a viable option.
Ramita brings more than 25 years of leadership and operational experience across a portfolio of industry-leading businesses and services in real-world evidence and patient-centered health outcomes. Prior to joining Walgreens, she served as the Chief Operating Officer at Trio Health, and prior to that she was the Executive Vice President, Commercialization and Outcomes at ICON. Ramita was recently named to the Center for Healthcare Innovation’s Board of Directors.
As a transformational leader, Ramita is passionate in her belief that a best-in-class operating model employing insights and innovation can deliver gains in operations and forge stronger connections with all stakeholders, including biopharmaceutical companies, healthcare systems and payers. Ramita was recently named to Drug Store News’ Top Women in Health, Wellness & Beauty class of 2022 for Business Excellence, Fierce Healthcare’s 2022 Women of Influence and she was listed in the 2018 PharmaVOICE 100. On top of her individual accolades, under Ramita’s leadership the Walgreens clinical trials business was nominated at the 2022 Prix Galien USA in the category for "Incubators, Accelerators and Equity," commended in the 2022 Clinical Trials Arena Excellence Awards, and was just shortlisted in the PRWeek Healthcare Awards 2023 “Best Healthcare Product Launch” category.
Ramita is an internationally recognized speaker and author whose focus is on how to bridge the gap between commercial and clinical development. She is a graduate of the University of Michigan and the Boston University School of Public Health.
